100,957 DENTSPLY SIRONA Inc. $XRAY Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 29.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 247,611 shares of the medical instruments supplier’s stock after selling 100,957 shares during the period. Fifth Third Bancorp owned 0.12% of DENTSPLY SIRONA worth $2,194,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in XRAY. Nykredit A S acquired a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $38,000. IFP Advisors Inc lifted its holdings in DENTSPLY SIRONA by 244.4% in the 3rd quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock worth $49,000 after purchasing an additional 3,950 shares during the last quarter. Allworth Financial LP acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $51,000. Public Employees Retirement System of Ohio acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $69,000. Finally, Citizens Financial Group Inc. RI bought a new stake in DENTSPLY SIRONA during the second quarter worth approximately $118,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on XRAY shares. Leerink Partners lowered their price target on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a report on Wednesday, October 14th. Zacks Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 9th. Bank of America reaffirmed a “buy” rating on shares of DENTSPLY SIRONA in a report on Friday, November 6th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday, October 22nd. Finally, UBS Group dropped their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, November 16th. Three equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $12.08.

Read Our Latest Stock Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $8.29 on Friday. The business has a 50 day moving average price of $9.21 and a 200 day moving average price of $11.11. DENTSPLY SIRONA Inc. has a twelve month low of $8.14 and a twelve month high of $14.76. The company has a market cap of $1.64 billion, a price-to-earnings ratio of -13.37, a PEG ratio of 1.22 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 1.47.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The business had revenue of $836.00 million during the quarter, compared to analyst estimates of $861.68 million. During the same period last year, the business earned $0.37 EPS. The business’s quarterly revenue was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.21 earnings per share for the current year.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Further Reading

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.